/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
To shed pounds fast, Indians are going to great lengths to secure weight-loss drugs from abroad. Soon, they may not have to look elsewhere as US drugmaker Eli Lilly gets early approvals in India for its new weight-loss drug.
To shed pounds fast, Indians are going to great lengths to secure weight-loss drugs from abroad. Soon, they may not have to look elsewhere as US drugmaker Eli Lilly gets early approvals in India for its new weight-loss drug.
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.
Quick-commerce apps are likely to run into regulations and poor order volumes as they try to grow this business.
